Neuroprotectins and Maresins for Macrophages in Diabetic Wound Healing

糖尿病伤口愈合中巨噬细胞的神经保护素和 Maresins

• 批准号: 8302499
• 负责人: Song Hong
• 金额: $ 4.53万
• 依托单位: LSU HEALTH SCIENCES CENTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2015-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8302499
• 关键词: American; Anabolism; Apoptosis; Autacoids; Complement; Complications of Diabetes Mellitus; Diabetes Mellitus; Diabetic mouse; Docosahexaenoic Acids; Endothelial Cells; F2-Isoprostanes; Fourier Transform; Generations; Glucose; Goals; Healed; Hyperglycemia; Impaired wound healing; Impairment; In Vitro; Kinetics; Lipids; Maps; Mass Spectrum Analysis; Mediator of activation protein; Medical; Modality; Modeling; Molecular; Mus; Non-Insulin-Dependent Diabetes Mellitus; Oxidative Stress; Play; Process; Recovery; Research; Role; Simulate; Site; Skin; Supplementation; Testing; Time; Vascularization; Wound Healing; angiogenesis; base; cell motility; cytokine; diabetic; diabetic wound healing; healing; in vivo; insight; knockout gene; lipid mediator; macrophage; non-diabetic; novel; novel therapeutics; public health relevance; tandem mass spectrometry; tool; wound

DESCRIPTION (provided by applicant): Many Americans suffer from the non-healing wound complications associated with diabetes. The goal of this project is to elucidate the mechanisms of action of endogenous pro-healing lipid autacoids of macrophages (PLAM), which we discovered recently, in diabetic impairments of wound healing. These PLAMs include neuroprotectins (NPDs) and maresins, PLAMs are autacoids acting on the site of their biosynthesis. Macrophages (Mf) play critical roles in wound healing. In our preliminary studies, we show that healthy murine Mf and skin after wounding generate NPD1, maresin-1, and other novel lipid mediators. In contrast, the levels of these PLAMs are diminished in comparable Mf and wounds of diabetic mice. Wound PLAM levels are inversely correlated with the levels of the oxidative stress marker F4-neuroprostane, an autooxidized derivative of DHA. Moreover, we show that hyperglycemia diminishes PLAM formation by Mf of diabetic mice. We also show that treating Mf of diabetic mice with these PLAMs rescue Mf pro-healing functions in wounds of diabetic mice. These novel findings led to our following hypotheses: 1) Diabetic complications diminish the formation of PLAMs required for normal wound healing; 2) Supplementation with these PLAMs rescues the pro-healing function of diabetes-impaired macrophages on wounds and angiogenesis. We will test our hypotheses using a wound healing model of murine gene-knockout type II diabetes, Mf depletion, vascularization assessments in vivo and in vitro, and analysis via tandem mass spectrometry (MS), including Fourier transform FTMS. The Specific Aims are: Aim 1. Test the predictions about PLAM formation and its relationship with Mf and diabetic hyperglycemia and oxidative stress during wound healing. We will study wounds and Mf using our targeted LC-UV-MS/MS based mediator-lipidomic analysis to test the prediction that: 1A. the levels of F2-isoprostanes and F4-neuroprostanes representing diabetic oxidative-stress are temporally and inversely correlated with the diminished PLAM formation in wounds of diabetic mice. 1B. simulated hyperglycemia diminishes PLAM formation by Mf. 1C. Mf depletion significantly reduces the PLAM formation in wounds of non-diabetic mice. Aim 2. Test that supplementation of neuroprotectins, maresins, or novel PLAMs rescues diabetes-impaired Mf functions that promote wound healing. We will apply diabetic mouse-produced Mf treated with these PLAMs to wounds of diabetic mice to establish their actions. Aim 3. Test that supplementation with PLAMs rescues diabetes-impaired Mf functions that promote wound-healing-required angiogenesis in hyperglycemia. We will treat diabetes-impaired Mf with PLAMs under high-glucose conditions to determine if PLAMs can rescue Mf in promoting crucial angiogenic processes of wound healing. Completion of this proposed research will contribute to revealing the molecular and cellular mechanisms for novel endogenous lipid autacoids necessary to rescue diabetes-impaired macrophage functions vital to wound healing, and provide new insight for developing novel therapeutic modalities for treating wounds in diabetics. PUBLIC HEALTH RELEVANCE: The proposed research will define the mechanisms that supplementation of maresins, neuroprotectins, and candidates of novel pro-healing lipid autacoids and paracoids rescues diabetes-impaired macrophages, which enhance the healing in diabetes-impaired wounds. These mechanisms may be potential targets for developing therapeutical strategies to cure the nonhealing of diabetes-impaired wounds.

描述（由申请人提供）：许多美国人患有与糖尿病相关的伤口不愈合并发症。本课题的目的是阐明我们最近发现的巨噬细胞内源性促愈合脂类自噬细胞（PLAM）在糖尿病伤口愈合损伤中的作用机制。这些plam包括神经保护素（npd）和mamains， plam是作用于其生物合成位点的类自身蛋白。巨噬细胞（Mf）在伤口愈合中起着至关重要的作用。在我们的初步研究中，我们发现健康小鼠的Mf和皮肤在受伤后产生NPD1， marsin -1和其他新的脂质介质。相比之下，这些PLAMs的水平在糖尿病小鼠的相似Mf和伤口中降低。伤口PLAM水平与氧化应激标志物f4 -神经前列腺素水平呈负相关，f4 -神经前列腺素是DHA的自氧化衍生物。此外，我们发现高血糖会减少糖尿病小鼠的Mf形成PLAM。我们还发现，用这些PLAMs治疗糖尿病小鼠的Mf可以恢复糖尿病小鼠伤口中Mf的促愈合功能。这些新发现导致了我们的假设：1)糖尿病并发症减少了正常伤口愈合所需的plam的形成；2)补充这些PLAMs可以恢复糖尿病损伤的巨噬细胞对伤口和血管生成的促愈合功能。我们将使用小鼠基因敲除II型糖尿病的伤口愈合模型、Mf耗竭、体内和体外血管化评估以及通过串联质谱（MS）分析（包括傅立叶变换FTMS）来验证我们的假设。具体目标是：目标1。验证伤口愈合过程中PLAM的形成及其与Mf、糖尿病高血糖和氧化应激的关系。我们将使用基于LC-UV-MS/MS的靶向介质脂质组学分析来研究伤口和Mf，以验证以下预测：a .代表糖尿病氧化应激的f2 -异前列腺素和f4 -神经前列腺素的水平与糖尿病小鼠伤口中PLAM形成的减少在时间上呈负相关。1 b。模拟高血糖通过Mf. 1C减少PLAM的形成。Mf耗竭显著减少非糖尿病小鼠创伤中PLAM的形成。目标2。测试补充神经保护素、maareins或新型PLAMs可拯救糖尿病受损的Mf功能，促进伤口愈合。我们将用这些pla处理糖尿病小鼠产生的Mf用于糖尿病小鼠的伤口，以确定它们的作用。目标3。测试补充PLAMs可拯救糖尿病受损的Mf功能，促进高血糖患者伤口愈合所需的血管生成。我们将在高糖条件下用PLAMs治疗糖尿病受损的Mf，以确定PLAMs是否可以在促进伤口愈合的关键血管生成过程中拯救Mf。本研究的完成将有助于揭示新的内源性脂质类脂素的分子和细胞机制，这些类脂素是恢复糖尿病损伤的巨噬细胞功能所必需的，对伤口愈合至关重要，并为开发新的治疗糖尿病患者伤口的治疗方式提供新的见解。